Cisbio Bioassays, now a member of the IBA group, is a life sciences company committed to improving human healthcare through the development of high-performance, biomedical technologies for biomarkers assessment and drug screening.
Cisbio Bioassays applies its 30 years of experience in the field of monoclonal antibodies and immunoassay design to the development, manufacturing and marketing of novel in vitro diagnostic assays for the quantification of biomarkers in clinical biology. This R&D-driven philosophy provides the medical community with reliable and sensitive diagnostic solutions both in RIA & ELISA formats.
As part of its on-going customer-oriented commitment, Cisbio Bioassays embarks on researching and introducing improved technologies to provide physicians, biologists, clinical chemists and scientists with enhanced solutions, such as companion tests, that improve patient care in the new context of personalized medicine.
© IBA 2009 | All rights reserved |
